{{Rsnum
|rsid=13192841
|Chromosome=6
|position=137646077
|Orientation=plus
|GMAF=0.1887
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|effect1=
|effect2=
|effect3=
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.0 | 31.0 | 61.1
| HCB | 0.7 | 17.6 | 81.6
| JPT | 0.9 | 17.0 | 82.1
| YRI | 1.4 | 13.8 | 84.8
| ASW | 1.8 | 28.1 | 70.2
| CHB | 0.7 | 17.6 | 81.6
| CHD | 0.0 | 19.3 | 80.7
| GIH | 14.1 | 44.4 | 41.4
| LWK | 0.0 | 12.8 | 87.2
| MEX | 6.9 | 48.3 | 44.8
| MKK | 1.3 | 23.4 | 75.3
| TSI | 7.8 | 45.1 | 47.1
| HapMapRevision=28
}}

An association was found between Systemic lupus erythematosus ([[SLE]]) and [[rs13192841]].{{PMID|18677310}}

Three independent SNPs in the [[TNFAIP3]] region ([[rs13192841]], [[rs2230926]] and [[rs6922466]]) are associated with systemic lupus erythematosus ([[SLE]]) among individuals of European ancestry.{{PMID|19165919|OA=1
}}

{{omim
|desc=SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13
|id=612378
|rsnum=13192841
}}

{{PMID Auto
|PMID=20617138
|Title=Association of TNFAIP3 Polymorphism with Susceptibility to Systemic Lupus Erythematosus in a Japanese Population
|OA=1
}}

{{PMID Auto
|PMID=19169254
|Title=Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.
|OA=1
}}

{{PMID Auto
|PMID=19387456
|Title=Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations.
|OA=1
}}

{{PMID Auto
|PMID=19417005
|Title=Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23.
|OA=1
}}

{{PMID Auto
|PMID=20018022
|Title=Replication of recently identified associated single-nucleotide polymorphisms from six autoimmune diseases in Genetic Analysis Workshop 16 rheumatoid arthritis data.
|OA=1
}}

{{PMID Auto
|PMID=20018027
|Title=Conditional analysis of the major histocompatibility complex in rheumatoid arthritis.
|OA=1
}}

{{PMID Auto
|PMID=20444755
|Title=Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
|OA=1
}}

{{PMID Auto GWAS
  |PMID=21833088
  |Trait=Multiple sclerosis
  |Title=Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
  |RiskAllele=A
  |Pval=1E-8
  |OR=1.10
  |ORtxt=[1.09-1.12]
  |OA=1
}}

{{PMID Auto
|PMID=22328738
|Title=Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}